We are live on
!
Find out more
APM
Avidity Partners Management Portfolio holdings
AUM
$936M
1-Year Est. Return
195%
This Fund
S&P 500
This Quarter
Est. Return
-7.96%
1 Year Est. Return
+195%
3 Year Est. Return
+460.87%
5 Year Est. Return
+815.5%
10 Year Est. Return
–
AUM
$1B
AUM Growth
-$957M
(-49%)
Cap. Flow
-$780M
Cap. Flow
% of AUM
-77.79%
Top 10 Holdings %
Top 10 Hldgs %
37.12%
Holding
85
New
4
Increased
6
Reduced
47
Closed
24
Top Buys
| 1 |
Transmedics
TMDX
|
+$15.3M |
| 2 |
Janux Therapeutics
JANX
|
+$9.52M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$7.05M |
| 4 |
DexCom
DXCM
|
+$5.77M |
| 5 |
Rocket Pharmaceuticals
RCKT
|
+$4.58M |
Top Sells
| 1 |
Natera
NTRA
|
+$48.4M |
| 2 |
Intuitive Surgical
ISRG
|
+$43.4M |
| 3 |
Boston Scientific
BSX
|
+$39.3M |
| 4 |
Neurocrine Biosciences
NBIX
|
+$29.6M |
| 5 |
Illumina
ILMN
|
+$26M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Dianthus Therapeutics
DNTH
$5.46B
| $62.6M | 6.24% |
2,873,000
-44,231
| -2% | -$1.14M |
|
|
2
Boston Scientific
BSX
$64B
| $46M | 4.59% |
515,000
-447,000
| -46% | -$39.3M |
|
|
3
Janux Therapeutics
JANX
$978M
| $39.7M | 3.96% |
741,900
+179,900
| +32% | +$9.52M |
|
|
4
Natera
NTRA
$39.7B
| $35.4M | 3.53% |
223,800
-332,600
| -60% | -$48.4M |
|
|
EXAS
5
DELISTED
Exact Sciences
EXAS
| $33.9M | 3.38% |
603,011
+15,011
| +3% | +$934K |
|
|
6
Intuitive Surgical
ISRG
$138B
| $33.8M | 3.37% |
64,800
-83,400
| -56% | -$43.4M |
|
7
CG Oncology
CGON
$6.44B
| $31.5M | 3.14% |
1,097,800
-558,200
| -34% | -$19.1M |
|
8
UnitedHealth
UNH
$380B
| $30.4M | 3.03% |
60,000
-27,400
| -31% | -$15.6M |
|
|
9
Neurocrine Biosciences
NBIX
$17.3B
| $30.1M | 3% |
220,400
-239,600
| -52% | -$29.6M |
|
10
IDEAYA Biosciences
IDYA
$3.54B
| $29M | 2.89% |
1,126,700
-246,300
| -18% | -$6.97M |
|
11
Jazz Pharmaceuticals
JAZZ
$15B
| $28.9M | 2.88% |
234,500
-196,500
| -46% | -$23.2M |
|
12
Mirum Pharmaceuticals
MIRM
$7.38B
| $27.5M | 2.75% |
666,200
-64,904
| -9% | -$2.7M |
|
13
Acadia Healthcare
ACHC
$2.97B
| $26.1M | 2.6% |
658,000
-327,000
| -33% | -$14.7M |
|
14
Arvinas
ARVN
$534M
| $26M | 2.6% |
1,358,000
-139,000
| -9% | -$3.38M |
|
15
Glaukos
GKOS
$9.21B
| $25.5M | 2.54% |
170,000
-174,900
| -51% | -$24.1M |
|
|
16
DexCom
DXCM
$28.1B
| $24.7M | 2.47% |
318,000
+78,000
| +33% | +$5.77M |
|
17
Thermo Fisher Scientific
TMO
$199B
| $23.2M | 2.31% |
44,600
-24,000
| -35% | -$13.2M |
|
18
Humana
HUM
$49B
| $22.6M | 2.26% |
89,200
-40,500
| -31% | -$10.9M |
|
19
Kymera Therapeutics
KYMR
$9.39B
| $20.1M | 2.01% |
500,000
| – | – |
|
20
Avantor
AVTR
$7.65B
| $20M | 1.99% |
947,000
-288,000
| -23% | -$6.48M |
|
21
Syndax Pharmaceuticals
SNDX
$2.08B
| $19.8M | 1.98% |
1,500,000
-955,000
| -39% | -$16.3M |
|
|
CNTA
22
DELISTED
Centessa Pharmaceuticals
CNTA
| $19.5M | 1.95% |
1,165,800
-966,200
| -45% | -$16M |
|
23
Revolution Medicines
RVMD
$39.2B
| $19.5M | 1.95% |
446,200
-343,800
| -44% | -$17.4M |
|
24
Xenon Pharmaceuticals
XENE
$6.55B
| $18.6M | 1.85% |
474,000
-344,000
| -42% | -$14.2M |
|
25
Tenet Healthcare
THC
$16.6B
| $17.3M | 1.72% |
137,000
-116,000
| -46% | -$17.2M |
|
Similar funds
NM
LM
IF
PWAM
CM
LJAC
PO
SH